Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study

Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study

Perinuclear Anti Neutrophil Cytoplasmic Antibody (p-ANCA) is a serological marker of Microscopic Polyangiitis (MPA), a vasculitis associated with lung involvement potentially mimicking Idiopathic Pulmonary Fibrosis (IPF). In this study, we evaluated the role of p-ANCA in predicting clinical evolutio...

Full description

Bibliographic Details
Main Authors:	Alessandro Libra, Giuseppe Muscato, Giuseppe Ielo, Lucia Spicuzza, Stefano Palmucci, Evelina Fagone, Mary Fruciano, Elisa Gili, Gianluca Sambataro, Carlo Vancheri
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Diagnostics
Subjects:	idiopathic pulmonary fibrosis ANCA vasculitis Microscopic Polyangiitis Rheumatoid Factor UIP pattern
Online Access:	https://www.mdpi.com/2075-4418/13/11/1882

Similar Items

Update of Management of ANCA-Associated Vasculitis
by: Hoi San Tang, et al.
Published: (2021-12-01)

ANCA Associated Mononeuritis Multiplex with Overlap in Vasculitic Syndromes
by: Ravi Anadure, et al.
Published: (2017-01-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California
by: Deepika Singh, et al.
Published: (2023-07-01)

Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis
by: Kazuyuki Tsuboi, et al.
Published: (2022-10-01)

Presentation and progression of MPO-ANCA interstitial lung disease
by: Lorenzo Salvati, et al.
Published: (2024-06-01)

Clinical characteristics and long-term survival differences of the ANCA-associated vasculitis group: a cross-sectional study of 27 patients
by: Jolanta Dadonienė, et al.
Published: (2017-07-01)

Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies
by: Adél Molnár, et al.
Published: (2022-06-01)

Serum 20S proteasome levels are associated with disease activity in MPO-ANCA-associated microscopic polyangiitis
by: Hiroshi Maruyama, et al.
Published: (2020-08-01)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
by: Dario Roccatello, et al.
Published: (2022-03-01)

Primary Vasculitis in Childhood: GPA and MPA in Childhood
by: Mehul P. Jariwala, et al.
Published: (2018-08-01)

Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature
by: Spoerl David, et al.
Published: (2012-12-01)

Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study
by: Aya Kawasaki, et al.
Published: (2020-10-01)

Evolution of views on ANCA-associated glomerulonephritis
by: T V Beketova, et al.
Published: (2008-12-01)

Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study
by: Alicia Rodriguez-Pla, et al.
Published: (2021-04-01)

A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fcγ-RIIa Genes
by: Ulf Persson, et al.
Published: (2013-12-01)

Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients
by: Philipp S. Fuchs, et al.
Published: (2020-12-01)

Clinical features of kidney involvement in microscopic microscopic polyangiitis
by: E M Shchegoleva, et al.
Published: (2018-06-01)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
by: Robson JC, et al.
Published: (2018-01-01)

Granulomatosis with polyangiitis: An atypical initial presentation
by: Catarina Vilaça Pereira, et al.
Published: (2022-01-01)

Clinical and immunological variants of ANCA-associated systemic vasculitis: a look at the pulmonary fibrosis in microscopic polyangiitis with anti-myeloperoxidase antibodies and rheumatoid factor. Literature review and own observation
by: T. V. Beketova, et al.
Published: (2023-03-01)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
by: Thomas Hellmark, et al.
Published: (2019-03-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT
by: L. M. Kudelya, et al.
Published: (2020-03-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
by: T V Beketova
Published: (2018-05-01)

Granulomatosis with polyangiitis: a 17 year experience from a tertiary care hospital in Pakistan
by: Omar Irfan, et al.
Published: (2018-05-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Multiple Cutaneous Manifestations in ANCA-Positive Eosinophilic Granulomatosis with Polyangiitis before and after Biologic Therapy: Clinical and Histopathologic Characterization of a Paradigmatic Case
by: Giorgia Carnicelli, et al.
Published: (2022-12-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

COVID-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2018-06-01)

ANCA-associated vasculitis with cardiac valve vegetations in two teenage males: two case reports and a literature review
by: Alexandra Theisen, et al.
Published: (2022-10-01)

CLINICAL AND LABORATORY FEATURES OF ANCA ASSOCIATED VASCULITIS: EXPERIENCE AT A TERTIARY CARE HOSPITAL IN LAHORE, PAKISTAN
by: Muhammad Zeeshan Aslam, et al.
Published: (2021-02-01)

Microscopic polyangiitis initially presenting with idiopathic pulmonary fibrosis: a case report
by: Chi Shao, et al.
Published: (2023-05-01)

Granulomаtosis With Polyangiitis Affecting the Lung and Orbit
by: Zh. V. Sheikh, et al.
Published: (2021-06-01)

Serum ANCA and Overall Mortality: A 10-Year Retrospective Cohort Study on 1,024 Italian Subjects
by: Enrico Brunetta, et al.
Published: (2021-09-01)

Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature
by: Yasunori Miyamoto, et al.
Published: (2019-04-01)

ANCA-ASSOCIATED VASCULITIS: HETEROGENEITY OF CLINICAL MANIFESTATIONS, PROGNOSIS, CURRENT OPPORTUNITIES OF PHARMACOTHERAPY
by: O.B. Yaremenko, et al.
Published: (2017-11-01)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

An unsuspected histopathological finding —concomitant IgA nephropathy in a patient with ANCA-associated vasculitis: a case report and literature review
by: Maciej Tota, et al.
Published: (2023-08-01)